Angle Health

Health Tech · Insurtech · AI

Funding

Angle Health lands $600M Series C at $2.7B valuation

Two-thirds of the raise is secondary stock sales letting early investors cash out rather than fresh capital for the company.

• Angle Health raised $600M in equity at a $2.7B valuation, split into a $200M Series C and a $400M tender offer, led by Vitruvian Partners.
• Angle Health sells AI-powered, level-funded health plans to small businesses, serving over 5,000 employers across 47 states and turning profitable for four straight quarters.
• The $400M tender offer, which cashes out early backers and employees, priced at a $2.5B valuation, below the $2.7B figure attached to the new primary capital.
• Angle Health has now raised $334M in primary equity to date, arriving less than 10 months after a $134M Series B that combined debt and equity.
• The raise lands as U.S. employers face the largest jump in health insurance costs in two decades, with small businesses hit hardest by rising premiums.
• The deal shows investors betting that AI-driven underwriting can make small-group health coverage profitable at scale, a segment legacy insurers have long underserved.